Option Treatment Sample Clauses

Option Treatment. Prior to the Effective Time, Company shall take all actions necessary and appropriate to provide that immediately prior to the Effective Time, but subject to the Effective Time occurring, each unexpired and unexercised option, whether vested or unvested, to purchase shares of Company Common Stock (as defined in Section 2.2 hereof) under any stock option plan of Company (collectively, the “Company Plan Options”) including but not limited to the Company 1995 Stock Option Plan, and the 1995 Company Non-Employee Director’s Stock Option Plan (collectively, the “Company Option Plans”) and each other option, warrant or similar right to purchase shares of Company Common Stock (collectively, the “Company Non-Plan Options” and together with the Company Plan Options, the “Company Options”) set forth on Schedule 2.2, without regard to whether such option is then exercisable, shall be cancelled and, in exchange therefor, each former holder of any cancelled Company Option shall be entitled to receive, in consideration of the cancellation of such Company Option and in settlement therefor, a payment in cash (subject to any applicable withholding or other taxes required by applicable law to be withheld) of an amount equal to the product of (A) the total number of shares of Company Common Stock previously subject to such Company Options and (B) the excess, if any, of the Per Share Amount (as defined below) over the exercise price per share of Company Common Stock previously subject to such option plus, if applicable, the per share cash value of the Additional Merger Consideration such holder would have received if such holder had exercised his or her Company Options prior to the Effective Time, less any applicable tax withholding (such amounts payable hereunder being referred to collectively as the “Option Payments”). From and after the Effective Time, any such cancelled Company Options shall no longer be exercisable by the former holder thereof, but shall only entitle such holder, subject to receipt by the Exchange Agent (as defined in Section 1.9(a)) of the surrendered Company Option agreement, together with a written instrument, reasonably satisfactory to Acquisition Co., duly executed by the holder of such Company Option, representing that (i) he, she or it is the owner of all Company Options represented by such Company Option agreement and (ii) a confirmation of, and consent to, the cancellation of all of his, her or its Options, to the payment of the applicable Option...
Sample 1Sample 2
AutoNDA by SimpleDocs
Option Treatment. As of the Effective Time, all outstanding options to purchase Holdings Common Shares granted by Holdings pursuant to its stock option plans or otherwise (the “Options”), whether vested or unvested, whether or not exercisable, shall by virtue of the Merger be automatically canceled and retired and shall cease to exist and the sole right of the holders of the Options (“Optionholders”) with respect to such Options shall be the right to receive, in respect of those Options which are, or will be at the Closing, vested (or that automatically vest in connection with the Merger), payments in cash equal to (a) the respective amounts set forth opposite their names on Schedule 2.05 (as adjusted to reflect adjustments to the cash portion of the Merger Consideration pursuant to Section 2.03(b)), payable on the Closing Date minus the aggregate exercise price at which such Option is exercisable immediately prior to the Effective Time, and (b) the product of any Per Share Escrow Consideration multiplied by the number of Holding Common Shares issuable upon the exercise of the Options held by such Optionholder immediately prior to the Effective Time. All payments to Optionholders shall be treated as compensation when such consideration is actually paid, and each such payment shall be subject to and reduced by all applicable federal, state and local withholding Taxes. The Board of Directors of Holdings shall adopt such resolutions and take such actions as may be required to cause each Option outstanding at the Effective Time to be terminated in accordance with this Section 2.05.
Sample 1
Option Treatment. The Company has taken all actions necessary (under any Stock Plan, any applicable Legal Requirement, the stock option award agreements or otherwise) to effectuate the provisions of Section 1.2 and to ensure that, from and after the Closing, each individual who held an Option at any time prior to the Closing shall cease to have any rights with respect thereto, except as specifically set forth in Section 1.2(a).
Sample 1
Option Treatment. (a) Pursuant to the EXACT Sciences Corporation 2000 Stock Option and Incentive Plan and subject to the associated stock option agreements (collectively “Equity Documents”), as of March 31, 2009, Executive held vested and unvested options to purchase 620,000 shares of the Company’s stock with an exercise price of greater than $2.00 per share (collectively, the “Repurchase Options”). In lieu of accelerated vesting, an extension of the option exercise period and any other enhanced equity rights whether arising from the Employment Agreement, the Equity Documents or otherwise, the Company shall repurchase from Executive all of the Repurchase Options for an aggregate purchase price of $39,100 (the “Repurchase”), less applicable deductions and withholdings. The Repurchase will take place on March 31, 2009. Executive acknowledges and agrees that, after the Repurchase, he will have no further interest in any of the Repurchase Options. (b) As of March 31, 2009, Executive held vested and unvested options to purchase 175,000 shares of the Company’s stock with an exercise price of $1.83 per share (collectively, the “Acceleration Options”). Pursuant to the terms of the Equity Documents and the Employment Agreement, all unvested Acceleration Options that by their original terms would become exercisable within nine (9) months following the last day of Executive’s employment with the Company shall immediately accelerate and become fully exercisable as of the last day of Executive’s employment with the Company, and all other unvested Acceleration Options shall terminate as of such date. In addition, pursuant to the terms of the Equity Documents and the Employment Agreement, Executive may exercise any vested Acceleration Options (including any previously-unvested Acceleration Options that vest pursuant to this Section 5(b)) until the date which is two (2) years after the last day of Executive’s employment with the Company (but not in any event later than the expiration date of the Acceleration Options).
Sample 1
Option Treatment. Each Share subject to an option (other than an option held by a shareholder of Purchaser which shall be cancelled or assumed by the Purchaser) outstanding immediately prior to the consummation of the Offer shall be settled in cash by Purchaser at the time of the consummation of the Offer for an amount equal to the positive difference between the Offer Price and the per Share exercise price, or, if the per Share exercise price equals or exceeds the Offer Price, the outstanding option shall be cancelled upon the consummation of the Offer.
Sample 1
Option Treatment. Consultant currently holds the following options to purchase Common Stock (the "Options") issued under MSI's 1985 Stock Option Plan, as amended to date (the "Plan"): Incentive Stock Option Agreement dated November 5, 1992, relating to 10,000 shares of the Company's Common Stock at an exercise price of $1.65 per share; and Incentive Stock Option Agreement dated September 10, 1993, relating to 20,000 shares of the Company's Common Stock at an exercise price of $6.1875. With respect to the Options, MSI and the Consultant have agreed that notwithstanding the provisions of Section 5(e) of the Plan and the corresponding provisions of the Options, the Board of Directors of the Company acting pursuant to Sections 5(h) and 10 of the Plan, has agreed to waive the provisions of such sections requiring exercise of the options during a prescribed period following termination of Consultant's employment by the Company and to provide that the Options shall remain exercisable by Consultant following expiration or termination of this Agreement for the full remainder of the specified term thereof subject only to the provisions of the Options related to exercise of the Options upon the death of Employee (Section 5(e)(ii) of the Plan). Employee acknowledges that the amendment to the Options set forth above shall result in the Options no longer qualifying as "incentive stock options" under the Plan and therefore that the Options will not qualify for the favorable tax treatment afforded incentive stock options under Section 422 of the Internal Revenue Code. Accordingly, the Options shall hereafter be subject to taxation as "non-statutory options" for tax purposes and will have the tax treatment afforded such type of options including the applicable withholding requirement upon exercise of the Options. In the event that the shares subject to the Options are not then registered with the Securities and Exchange Commission under an effective registration statement on Form S-8 (or other applicable form) and further in the event that such shares may in the opinion of counsel to the Company be subject to restrictions on their resale under the federal securities laws (other than a filing of a notice of sale under Rule 144 of the federal securities laws), then the Company grants to Consultant "piggyback" registration rights with respect to the shares issuable upon exercise of the Options with regard to registrations of Company Common Stock under the Securities Act of 1933, as amended, in...
Sample 1
Option Treatment. (a) Provided that the undersigned has satisfied and complied with the Separation Benefit Conditions: (i) as of the Separation Date, after giving effect to the undersigned’s termination of employment without “cause”, all of the undersigned’s vested Base Options will be vested (i.e., 12,750 Base Options will become vested); (ii) the exercise period applicable to each of the Base Options will be extended to its Normal Termination Date (as defined in the Option Agreement), which is the 10th anniversary of its grant date (the “Extended Option Date”), and any Base Options that are not exercised on or prior to the Extended Option Date, will terminate without consideration immediately thereafter; (iii) in the event that Topco completes a Public Offering (as defined in the Amended and Restated Agilon Health Topco, Inc. Stock Incentive Plan (the “Stock Incentive Plan”)) on or prior to the Extended Option Date, Topco will permit the undersigned to exercise, subject to the terms and conditions in the Option Agreement, (x) all or any then outstanding Base Options on a cashless basis in the Public Offering and (y) after the Public Offering is completed and on or prior to the Extended Option Date, any then outstanding Base Options outstanding using a broker-assisted cashless exercise program or same day sale; and (iv) in the event that the undersigned exercises any Base Options prior to the Public Offering, neither he, Topco nor the CD&R Investor will have any rights to cause or obligations to participate in, a repurchase due to his termination of employment of any Option Shares acquired in any such exercise. (b) All Upside Options will be unvested as of the Separation Date and therefore will be automatically forfeited without any consideration as of the Separation Date.
Sample 1
AutoNDA by SimpleDocs

Related to Option Treatment

  • Xxx Treatment We have not promised you any particular tax outcome from buying or holding the Note.

  • National Treatment and Most-favoured-nation Treatment (1) Each Contracting Party shall accord to investments of investors of the other Contracting Party, treatment which shall not be less favourable than that accorded either to investments of its own or investments of investors of any third State. (2) In addition, each Contracting Party shall accord to investors of the other Contracting Party, including in respect of returns on their investments, treatment which shall not be less favourable than that accorded to investors of any third State. (3) The provisions of paragraphs (1) and (2) above shall not be construed so as to oblige one Contracting Party to extend to the investors of the other the benefit of any treatment, preference or privilege resulting from: (a) Any existing or future free trade area, customs unions, monetary union or similar international agreement or other forms of regional cooperation to which one of the Contracting Parties is or may become a party, or (b) Any matter pertaining wholly or mainly to taxation.

  • Sale Treatment The Company has determined that the disposition of the Mortgage Loans pursuant to this Agreement will be afforded sale treatment for accounting and tax purposes;

  • Medical Treatment Undersigned understands that the Released Parties do not have medical personnel available at the location of the activities. Undersigned hereby grants the Released Parties permission to administer first aid or to authorize emergency medical treatment, if necessary. Undersigned understands and agrees that any such action by the Released Parties shall be subject to the terms of this agreement and release, including any liability arising from the negligence of the Released Parties when administering first aid or authorizing others to do so. Undersigned understands and agrees that the Released Parties do not assume responsibility for any injury or damage which might arise out of or in connection with such authorized emergency medical treatment.

  • National Treatment In the sectors inscribed in its Schedule, and subject to any conditions and qualifications set out therein, each Party shall accord to services and service suppliers of the other Party treatment no less favourable than that it accords, in like circumstances, to its own services and service suppliers.

  • Denial of Preferential Tariff Treatment The Customs Authority of the importing Party may deny a claim for preferential tariff treatment when: (a) the good does not qualify as an originating good; or (b) the importer, exporter or producer fails to comply with any of the relevant requirements of this Chapter.

  • REIT Treatment The Company will use its reasonable efforts to enable the Company to continue to meet the requirements to qualify for taxation as a REIT under the Code for subsequent tax years that include any portion of the term of this Agreement except as otherwise determined by the Board of Directors of the Company to be in the best interests of stockholders.

  • Reorganization Treatment Neither the Company nor any Company Subsidiary has taken or agreed to take any action that would prevent the Merger from constituting a reorganization qualifying under the provisions of Section 368(a) of the Code.

  • Corporate Treatment The Board shall use its reasonable best efforts to take such actions as are necessary or appropriate to preserve the status of the Company as a partnership for U.S. federal (and applicable state and local) income tax purposes. If, however, the Board determines, in its sole discretion, for any reason (including the proposal, formally or informally, of legislation that could affect the Company’s status as a partnership for U.S. federal and/or applicable state and local income tax purposes) that it is not in the best interests of the Company to be characterized as a partnership, the Board may take whatever steps, if any, are needed to cause the Company to be or confirm that the Company will be treated as an association or as a publicly traded partnership taxable as a corporation for U.S. federal (and applicable state and local) income tax purposes, including by making an election to be taxed as a “C” corporation pursuant to the Code (a “Change in Tax Classification”), without any approval or vote of the Members required, and to make such filings, including without limitation, a Form 8832 with the Service, and to undertake such actions as required to effect such Change in Tax Classification. At the time and following any Change of Tax Classification, the Board shall have the right, without any approval or vote of the Members being required, to amend this Agreement as reasonably required to effect the Change in Tax Classification and to provide for the operations of the Company following such event. Notwithstanding anything in this Agreement to the contrary, in the event U.S. federal (and/or applicable state and local) income tax laws, rules or regulations are enacted, amended, modified or applied after the date hereof in such a manner as to require or necessitate that the Company no longer be treated as a partnership for U.S. federal (and/or applicable state and local) income tax purposes, then the first sentence of this Section 8.7 shall no longer apply.

  • Emergency Medical Treatment I grant the Releasees permission to authorize emergency medical treatment as they deem appropriate, and agree that such action by the Releasees shall be subject to the terms of this Agreement. I understand and agree that the Releasees assume no responsibility for any injury or damage that might result from such emergency medical treatment.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!